Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients-Reference-Cited by-同舟云学术

Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients

Published:2017-07 Issue:7 Volume:27 Page:647-656
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Mas Sergi,Gassó Patricia,Torra Mercé,Bioque Miquel,Lobo Antonio,González-Pinto Ana,Olmeda Maria Soledad,Corripio Iluminada,Vieta Eduard,Castro-Fornieles Josefina,Rodriguez-Jimenez Roberto,Bobes Julio,Usall Judith,Llerena Adrián,Saiz-Ruiz Jerónimo,Bernardo Miguel,Lafuente Amalia,PEPs Group

Funder

Ministerio de Economía y Competitividad

Government of Catalonia, Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference34 articles.

1. The role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactions;Berecz;Curr. Drug Targets,2004

2. Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients;Berecz;Pharmacopsychiatry,2002

3. Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs);Bernardo;Rev. Psiquiatr. Salud Ment.,2013

4. A pharmacovigilance study in first episode of psychosis: psychopharmacological interventions and safety profiles in the PEPs Project;Bioque;Int. J. Neuropsychopharmacol,2015

5. A power primer;Cohen;Psychol. Bull.,1992

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure;JAMA Psychiatry;2021-03-01

2. Applying Pharmacogenomics in Drug Therapy of Neurologic and Psychiatric Disorders;Reference Module in Biomedical Sciences;2021

3. Allelic and phenotypic characterization of CYP2D6 and its encoded P450 cytochrome enzyme in a serie of Spanish type 1 Gaucher disease patients;Medicina Clínica;2020-12

4. Allelic and phenotypic characterization of CYP2D6 and its encoded P450 cytochrome enzyme in a serie of Spanish type 1 Gaucher disease patients;Medicina Clínica (English Edition);2020-12

5. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis;Psychopharmacology;2020-11-23